A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer
Clinical trial NCT03507166 · COMPLETED
Trial details
- NCT number
- NCT03507166
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-28
- Primary completion
- 2018-10-29
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.